Trial Profile
The effect of bisphosphonates on disease activity and bone status in ankylosing spondylitis
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Alendronic acid (Primary) ; Risedronic acid
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- Acronyms BIAS
- 19 Jul 2005 New trial record.